diagnostics


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

diagnostics

[‚dī·əg′näs·tiks]
(engineering)
Information on what tests a device has failed and how they were failed; used to aid in troubleshooting.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.

diagnostics

(1) Software routines that test hardware components (memory, keyboard, disks, etc.). Diagnostics are often stored in ROM chips and activated on startup.

(2) Error messages in a programmer's source code that refer to statements or syntax that the compiler or assembler cannot understand.
Copyright © 1981-2019 by The Computer Language Company Inc. All Rights reserved. THIS DEFINITION IS FOR PERSONAL USE ONLY. All other reproduction is strictly prohibited without permission from the publisher.
References in periodicals archive ?
"The Global Autoimmune Disease Diagnostic Market is expected to surpass US$ 18 Billion by the year end of 2025."
Through its Amplidiag and Novodiag solutions, Mobidiag offers a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases to laboratories of all sizes.
In April 2018, Blue Earth Diagnostics expanded its prostate cancer portfolio through the acquisition of exclusive, worldwide rights to a broad family of Prostate Specific Membrane Antigen -targeted radiohybrid agents for cancer.
North America was the key region in global cancer diagnostics market in terms of revenue in 2014, followed by Europe.
One of the main limitations of traditional companion diagnostics is the narrow scope of biomarker evaluation and the often high tissue requirements if multiple single biomarker tests are needed for therapy selection.
In 2009 Swinton Technology partnered with DP Diagnostics to create the industry ready "Prognosis" DP meter diagnostic system.
Centralized Diagnostics provides integrated, high-performance analytical systems to optimize laboratory management from pre-analytical to post-analytical processes.
An overview of current TB diagnostics is given in the second chapter.
For companies that make products for nucleic acid preparation and analysis for research applications, the transition to molecular diagnostics is a natural progression as their technology platforms can also be utilized to analyze patient samples for diagnostic purposes.
QIAGEN N.V., a Netherlands holding company, is a leading provider of innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions.
Both firms are active in the immunochemistry business, a sub-segment of IVD, which involves diagnostics for fertility, allergies, cancer and other pathologies.

Full browser ?